Core Scientific, Inc. $CORZ Shares Acquired by Sanders Morris Harris LLC

Sanders Morris Harris LLC boosted its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 2,786.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 308,855 shares of the company’s stock after acquiring an additional 298,155 shares during the quarter. Core Scientific accounts for about 0.7% of Sanders Morris Harris LLC’s portfolio, making the stock its 21st biggest holding. Sanders Morris Harris LLC’s holdings in Core Scientific were worth $5,190,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Nisa Investment Advisors LLC raised its position in shares of Core Scientific by 192.3% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,662 shares of the company’s stock worth $80,000 after purchasing an additional 3,067 shares during the last quarter. Kingswood Wealth Advisors LLC purchased a new stake in Core Scientific during the 2nd quarter worth approximately $243,000. Heritage Oak Wealth Advisors LLC increased its stake in Core Scientific by 2.4% during the 2nd quarter. Heritage Oak Wealth Advisors LLC now owns 753,846 shares of the company’s stock worth $12,868,000 after buying an additional 17,709 shares in the last quarter. Harvest Portfolios Group Inc. raised its holdings in shares of Core Scientific by 81.9% during the second quarter. Harvest Portfolios Group Inc. now owns 134,895 shares of the company’s stock valued at $2,303,000 after acquiring an additional 60,746 shares during the last quarter. Finally, Prudential Financial Inc. lifted its position in shares of Core Scientific by 1,326.9% in the second quarter. Prudential Financial Inc. now owns 199,630 shares of the company’s stock valued at $3,408,000 after acquiring an additional 185,640 shares in the last quarter.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, Director Eric Stanton Weiss purchased 5,000 shares of the stock in a transaction dated Tuesday, November 4th. The stock was acquired at an average cost of $21.50 per share, for a total transaction of $107,500.00. Following the acquisition, the director owned 226,687 shares in the company, valued at $4,873,770.50. This trade represents a 2.26% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.40% of the company’s stock.

Core Scientific Price Performance

Shares of NASDAQ CORZ opened at $14.73 on Wednesday. The company has a market capitalization of $4.57 billion, a P/E ratio of 98.21 and a beta of 6.77. The company has a 50 day simple moving average of $17.86 and a 200-day simple moving average of $15.63. Core Scientific, Inc. has a 1 year low of $6.20 and a 1 year high of $23.63.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Friday, October 24th. The company reported ($0.46) earnings per share for the quarter, topping the consensus estimate of ($0.85) by $0.39. The business had revenue of $81.10 million during the quarter, compared to analysts’ expectations of $107.18 million. As a group, research analysts expect that Core Scientific, Inc. will post 0.52 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently commented on CORZ. Jefferies Financial Group set a $24.00 price objective on Core Scientific and gave the company a “buy” rating in a research note on Tuesday, October 28th. B. Riley raised shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $30.00 price target on the stock in a research note on Wednesday, October 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a research report on Wednesday, October 8th. Macquarie upgraded shares of Core Scientific from a “hold” rating to an “outperform” rating and increased their price objective for the company from $18.00 to $34.00 in a report on Friday, October 31st. Finally, Roth Capital restated a “buy” rating on shares of Core Scientific in a report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Core Scientific currently has an average rating of “Moderate Buy” and a consensus price target of $22.39.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.